These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21826965)

  • 1. [Imaging bone metastases in breast cancer].
    Withofs N; Collignon J; Hustinx R
    Rev Med Liege; 2011; 66(5-6):291-8. PubMed ID: 21826965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
    Buscombe JR; Holloway B; Roche N; Bombardieri E
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
    Al-Muqbel KM; Yaghan RJ
    Medicine (Baltimore); 2016 May; 95(21):e3753. PubMed ID: 27227942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
    Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
    Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging bone metastases in breast cancer: evidence on comparative test accuracy.
    Houssami N; Costelloe CM
    Ann Oncol; 2012 Apr; 23(4):834-43. PubMed ID: 21896542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of (18)F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis.
    Niikura N; Hashimoto J; Kazama T; Koizumi J; Ogiya R; Terao M; Oshitanai R; Morioka T; Tsuda B; Okamura T; Saito Y; Iwaisako K; Iwamoto T; Hayashi N; Imai Y; Tokuda Y
    Breast Cancer; 2016 Jul; 23(4):662-7. PubMed ID: 26037335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.
    Withofs N; Grayet B; Tancredi T; Rorive A; Mella C; Giacomelli F; Mievis F; Aerts J; Waltregny D; Jerusalem G; Hustinx R
    Nucl Med Commun; 2011 Mar; 32(3):168-76. PubMed ID: 21076343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer.
    Iagaru A; Minamimoto R
    PET Clin; 2018 Jul; 13(3):383-393. PubMed ID: 30100077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging.
    Pires AO; Borges US; Lopes-Costa PV; Gebrim LH; da Silva BB
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():138-41. PubMed ID: 25037283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heterogeneity of bone metastases in a patient with breast cancer: case report illustrating the potential of combining various imaging techniques].
    Withofs N; Collignon J; Rorive A; Jerusalem G; Hustinx R
    Rev Med Liege; 2011; 66(5-6):288-90. PubMed ID: 21826964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview.
    Azad GK; Taylor B; Rubello D; Colletti PM; Goh V; Cook GJ
    Clin Nucl Med; 2016 Jan; 41(1):e44-50. PubMed ID: 26402127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.
    Cook GJ; Azad GK; Goh V
    J Nucl Med; 2016 Feb; 57 Suppl 1():27S-33S. PubMed ID: 26834098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
    Koolen BB; Vegt E; Rutgers EJ; Vogel WV; Stokkel MP; Hoefnagel CA; Fioole-Bruining A; Vrancken Peeters MJ; Valdés Olmos RA
    Ann Nucl Med; 2012 Jan; 26(1):86-91. PubMed ID: 21953212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities.
    Vassiliou V; Andreopoulos D; Frangos S; Tselis N; Giannopoulou E; Lutz S
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):632-45. PubMed ID: 21530193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.